BRIEFLY

q Drug approved THE US Food and Drug Administration said on Thursday it had approved Synergy Pharmaceuticals Inc’s drug to treat chronic idiopathic constipation. Synergy’s once-daily tablet, Trulance, is the company’s first to win regulatory clearance. However, the safety and effectiveness of the drug have not been established in patients less than 18 years of […]

Continue reading this article with a Fiji Times online membership.

More Stories